Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes
- 27 October 2015
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 203, 660-666
- https://doi.org/10.1016/j.ijcard.2015.10.220
Abstract
No abstract availableKeywords
Funding Information
- University of Birmingham
This publication has 45 references indexed in Scilit:
- Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial FibrillationCirculation: Heart Failure, 2013
- Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection FractionJournal of the American Heart Association, 2013
- Individual patient data meta-analysis of beta-blockers in heart failure: rationale and designSystematic Reviews, 2013
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United StatesCirculation: Cardiovascular Quality and Outcomes, 2011
- Atrial fibrillation in patients hospitalized for congestive heart failure: The same prognostic influence independently of left ventricular systolic function?International Journal of Cardiology, 2006
- Atrial fibrillation in heart failure: High mortality risk even if ventricular function is preservedAmerican Heart Journal, 2005
- Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarctionInternational Journal of Cardiology, 2005
- Acute Stroke With Atrial FibrillationStroke, 1996
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986